Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jakko van Ingen, Marko Obradovic, Mariam Hassan, Beth Lesher, Erin Hart, Anjan Chatterjee & Charles L. Daley. (2021) Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments. Expert Review of Respiratory Medicine 15:11, pages 1387-1401.
Read now
Read now
Andrew R. Turnbull & Jane C. Davies. (2016) New drug developments in the management of cystic fibrosis lung disease. Expert Opinion on Pharmacotherapy 17:8, pages 1103-1112.
Read now
Read now
Emma Vázquez-Espinosa, Rosa María Girón, Rosa Mar Gómez-Punter, Elena García-Castillo, Claudia Valenzuela, Carolina Cisneros, Enrique Zamora, F Javier García-Pérez & Julio Ancochea. (2015) Long-term safety and efficacy of tobramycin in the management of cystic fibrosis. Therapeutics and Clinical Risk Management 11, pages 407-415.
Read now
Read now
Articles from other publishers (36)
Xiaojing Ma, Wenjing Tang & Rong Yang. (2023) Bioinspired nanomaterials for the treatment of bacterial infections. Nano Research.
Crossref
Crossref
Qinqin Fei, Ian Bentley, Samir N. Ghadiali & Joshua A. Englert. (2023) Pulmonary drug delivery for acute respiratory distress syndrome. Pulmonary Pharmacology & Therapeutics 79, pages 102196.
Crossref
Crossref
Fatma Haddad, Nura Mohammed, R. C. Gopalan, Yousef Al Ayoub, Md Talat Nasim & K. H. Assi. (2023) Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach. Pharmaceutics 15:2, pages 539.
Crossref
Crossref
Debora Santonocito & Carmelo Puglia. (2023) Nanotechnological Systems and Lung: A Perfect Combination for
Lung Pharmaceutical Applications. Current Medicinal Chemistry 30:6, pages 725-743.
Crossref
Crossref
Aarti Belgamwar, Shagufta Khan & Mahendra Rai. 2023. Nanotechnology Principles in Drug Targeting and Diagnosis. Nanotechnology Principles in Drug Targeting and Diagnosis
3
17
.
Noorma Rosita, Andang Miatmoko, Devy Maulidya Cahyani & Dewi Melani Hariyadi. 2023. Infectious Diseases Drug Delivery Systems. Infectious Diseases Drug Delivery Systems
307
329
.
Xiaoting Shan, Xiang Gong, Jie Li, Jingyuan Wen, Yaping Li & Zhiwen Zhang. (2022) Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharmaceutica Sinica B 12:7, pages 3028-3048.
Crossref
Crossref
Paul J. Weldick, Anheng Wang, Ahmed F. Halbus & Vesselin N. Paunov. (2022) Emerging nanotechnologies for targeting antimicrobial resistance. Nanoscale 14:11, pages 4018-4041.
Crossref
Crossref
Wali Muhammad, Zihe Zhai, Shuqin Wang & Changyou Gao. (2021) Inflammation‐modulating nanoparticles for pneumonia therapy. WIREs Nanomedicine and Nanobiotechnology 14:2.
Crossref
Crossref
А.С. Зайцева, И.Э. Степанян & Е.И. Шмелев. (2022) МИКОБАКТЕРИОЗ ЛЕГКИХ: НЕРЕШЕННЫЕ ВОПРОСЫ АНТИБАКТЕРИАЛЬНОЙ ТЕРАПИИ, "Вестник Центрального научно-исследовательского института туберкулеза". Вестник ЦНИИТ:1, pages 6-16.
Crossref
Crossref
Xiang Wang, Zuozhou Xie, Jinhong Zhao, Zhenghua Zhu, Chen Yang & Yi Liu. (2021) Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Amala Maxwell, Vivek Ghate, Jesil Aranjani & Shaila Lewis. (2021) Breaking the barriers for the delivery of amikacin: Challenges, strategies, and opportunities. Life Sciences 284, pages 119883.
Crossref
Crossref
Chelsea R. Thorn, Nicky Thomas, Ben J. Boyd & Clive A. Prestidge. (2021) Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy. Drug Delivery and Translational Research 11:4, pages 1598-1624.
Crossref
Crossref
Pragya Prasanna, Shweta Rathee, Arun Upadhyay & Sulakshana Sulakshana. (2021) Nanotherapeutics in the treatment of acute respiratory distress syndrome. Life Sciences 276, pages 119428.
Crossref
Crossref
Wenhao Zhong, Xinyu Zhang, Yunxin Zeng, Dongjun Lin & Jun Wu. (2021) Recent applications and strategies in nanotechnology for lung diseases. Nano Research 14:7, pages 2067-2089.
Crossref
Crossref
Chelsea R. Thorn, Cristiane de Souza Carvalho‐Wodarz, Justus C. Horstmann, Claus‐Michael Lehr, Clive A. Prestidge & Nicky Thomas. (2021)
Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis‐Related
Pseudomonas aeruginosa
Biofilms
. Small 17:24, pages 2100531.
Crossref
Crossref
Eun-Mi KimHwan-Jeong Jeong. (2021) Liposomes: Biomedical Applications. Chonnam Medical Journal 57:1, pages 27.
Crossref
Crossref
Matteo Bassetti, Antonio Vena, Alessandro Russo & Maddalena Peghin. (2020) Inhaled Liposomal Antimicrobial Delivery in Lung Infections. Drugs 80:13, pages 1309-1318.
Crossref
Crossref
Varsha Komalla & Mehra Haghi. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
375
392
.
Mohammad Doroudian, Ronan MacLoughlin, Fergus Poynton, Adriele Prina-Mello & Seamas C Donnelly. (2019) Nanotechnology based therapeutics for lung disease. Thorax 74:10, pages 965-976.
Crossref
Crossref
Kamal Dua, Gaurav Gupta, Dinesh K. Chellappan, Shakti Shukla & Philip M. Hansbro. (2019) Targeting bacterial biofilms in pulmonary diseases in pediatric population. Minerva Pediatrica 71:3.
Crossref
Crossref
Disha Mehtani, Ankit Seth, Piyoosh Sharma, Neha Maheshwari, Devesh Kapoor, Sushant K. Shrivastava & Rakesh K. Tekade. 2019. Biomaterials and Bionanotechnology. Biomaterials and Bionanotechnology
89
152
.
Saman Fatima, Zeenat Iqbal, A.K. Panda, M. Samim, Sushama Talegaonkar & Farhan Jalees Ahmad. (2018) Polymeric nanoparticles as a platform for permeability enhancement of class III drug amikacin. Colloids and Surfaces B: Biointerfaces 169, pages 206-213.
Crossref
Crossref
Tatsuaki Tagami & Tetsuya Ozeki. (2017) Recent Trends in Clinical Trials Related to Carrier-Based Drugs. Journal of Pharmaceutical Sciences 106:9, pages 2219-2226.
Crossref
Crossref
Parastoo Sabaeifard, Ahya Abdi-Ali, Carlos Gamazo, Juan Manuel Irache & Mohammad Reza Soudi. (2017) Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa. Journal of Medical Microbiology 66:2, pages 137-148.
Crossref
Crossref
Vladimir Malinin, Mary Neville, Gina Eagle, Renu Gupta & Walter R. Perkins. (2016) Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats. Antimicrobial Agents and Chemotherapy 60:11, pages 6540-6549.
Crossref
Crossref
David L. Hava & Jean C. Sung. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment
325
345
.
Parastoo Sabaeifard, Ahya Abdi-Ali, Mohammad Reza Soudi, Carlos Gamazo & Juan Manuel Irache. (2016) Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa. European Journal of Pharmaceutical Sciences 93, pages 392-398.
Crossref
Crossref
Zora Rukavina & Željka Vanić. (2016) Current Trends in Development of Liposomes for Targeting Bacterial Biofilms. Pharmaceutics 8:2, pages 18.
Crossref
Crossref
Sneha Subramanian, Iftikhar Khan, Oshadie Korale, Mohamed Albed Alhnan, Waqar Ahmed, Mohammad Najlah, Kevin M.G. Taylor & Abdelbary Elhissi. (2016) A simple approach to predict the stability of phospholipid vesicles to nebulization without performing aerosolization studies. International Journal of Pharmaceutics 502:1-2, pages 18-27.
Crossref
Crossref
Jaideep S. Talwalkar & Thomas S. Murray. (2016) The Approach to Pseudomonas aeruginosa in Cystic Fibrosis. Clinics in Chest Medicine 37:1, pages 69-81.
Crossref
Crossref
Hinojal Zazo, Clara I. Colino & José M. Lanao. (2016) Current applications of nanoparticles in infectious diseases. Journal of Controlled Release 224, pages 86-102.
Crossref
Crossref
Katherine M. Langan, Tom Kotsimbos & Anton Y. Peleg. (2015) Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis. Current Opinion in Infectious Diseases 28:6, pages 547-556.
Crossref
Crossref
M. Moreno-Sastre, M. Pastor, C. J. Salomon, A. Esquisabel & J. L. Pedraz. (2015) Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy. Journal of Antimicrobial Chemotherapy 70:11, pages 2945-2955.
Crossref
Crossref
Tatsuaki Tagami, Masahito Kubota & Tetsuya Ozeki. (2015) Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration. Journal of Pharmaceutical Sciences 104:11, pages 3824-3832.
Crossref
Crossref
Adam Bohr & Moritz Beck-Broichsitter. (2015) Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems. Therapeutic Delivery 6:5, pages 621-636.
Crossref
Crossref